Free Trial

Saratoga Investment (SAR) Competitors

Saratoga Investment logo
$23.50 -0.66 (-2.71%)
As of 12:19 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SAR vs. OXLC, CET, GSBD, MFIC, NMFC, AWF, HQH, ASA, BBDC, and BCSF

Should you be buying Saratoga Investment stock or one of its competitors? The main competitors of Saratoga Investment include Oxford Lane Capital (OXLC), Central Securities (CET), Goldman Sachs BDC (GSBD), MidCap Financial Investment (MFIC), New Mountain Finance (NMFC), AllianceBernstein Global High Income Fund (AWF), abrdn Healthcare Investors (HQH), ASA Gold and Precious Metals (ASA), BARINGS BDC (BBDC), and Bain Capital Specialty Finance (BCSF). These companies are all part of the "financial services" industry.

Saratoga Investment vs. Its Competitors

Oxford Lane Capital (NASDAQ:OXLC) and Saratoga Investment (NYSE:SAR) are both small-cap financial services companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability.

In the previous week, Saratoga Investment had 3 more articles in the media than Oxford Lane Capital. MarketBeat recorded 5 mentions for Saratoga Investment and 2 mentions for Oxford Lane Capital. Saratoga Investment's average media sentiment score of 0.27 beat Oxford Lane Capital's score of -1.00 indicating that Saratoga Investment is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oxford Lane Capital
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative
Saratoga Investment
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

6.7% of Oxford Lane Capital shares are owned by institutional investors. Comparatively, 19.1% of Saratoga Investment shares are owned by institutional investors. 3.2% of Oxford Lane Capital shares are owned by insiders. Comparatively, 10.0% of Saratoga Investment shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Saratoga Investment has a consensus target price of $24.25, suggesting a potential upside of 3.77%. Given Saratoga Investment's stronger consensus rating and higher probable upside, analysts plainly believe Saratoga Investment is more favorable than Oxford Lane Capital.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oxford Lane Capital
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Saratoga Investment
0 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Saratoga Investment has a net margin of 24.85% compared to Oxford Lane Capital's net margin of 0.00%. Saratoga Investment's return on equity of 12.71% beat Oxford Lane Capital's return on equity.

Company Net Margins Return on Equity Return on Assets
Oxford Lane CapitalN/A N/A N/A
Saratoga Investment 24.85%12.71%4.04%

Oxford Lane Capital has a beta of 0.79, suggesting that its stock price is 21% less volatile than the S&P 500. Comparatively, Saratoga Investment has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500.

Oxford Lane Capital has higher revenue and earnings than Saratoga Investment. Oxford Lane Capital is trading at a lower price-to-earnings ratio than Saratoga Investment, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oxford Lane Capital$57.31M26.20$376.14M$4.153.99
Saratoga Investment$49.06M7.60$28.09M$2.479.46

Oxford Lane Capital pays an annual dividend of $5.35 per share and has a dividend yield of 32.3%. Saratoga Investment pays an annual dividend of $3.00 per share and has a dividend yield of 12.8%. Oxford Lane Capital pays out 128.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Saratoga Investment pays out 121.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Summary

Saratoga Investment beats Oxford Lane Capital on 11 of the 17 factors compared between the two stocks.

Get Saratoga Investment News Delivered to You Automatically

Sign up to receive the latest news and ratings for SAR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SAR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SAR vs. The Competition

MetricSaratoga InvestmentFIN IndustryFinance SectorNYSE Exchange
Market Cap$372.24M$1.44B$12.77B$21.99B
Dividend Yield12.25%12.38%5.51%3.56%
P/E Ratio9.4510.4130.3129.82
Price / Sales7.6042.4830.54102.30
Price / Cash8.969.9519.7218.33
Price / Book0.850.842.304.63
Net Income$28.09M$152.42M$1.02B$1.01B
7 Day Performance-4.19%-1.77%0.46%0.53%
1 Month Performance-5.66%-11.04%0.87%2.73%
1 Year Performance0.47%-13.09%541.52%14.35%

Saratoga Investment Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SAR
Saratoga Investment
1.5585 of 5 stars
$23.51
-2.7%
$24.25
+3.2%
+5.1%$373.52M$49.06M9.483,211
OXLC
Oxford Lane Capital
1.0257 of 5 stars
$16.68
-1.4%
N/A-36.4%$1.51B$57.31M4.02601Negative News
Short Interest ↑
CET
Central Securities
N/A$51.50
-0.2%
N/A+13.2%$1.49B$222.17M0.006News Coverage
Positive News
GSBD
Goldman Sachs BDC
1.6995 of 5 stars
$10.76
-1.2%
$10.00
-7.0%
-27.3%$1.24B$434.37M8.54N/A
MFIC
MidCap Financial Investment
3.0915 of 5 stars
$11.96
-0.7%
$13.30
+11.2%
-12.5%$1.12B$301.78M11.07N/ANews Coverage
Analyst Forecast
NMFC
New Mountain Finance
3.2099 of 5 stars
$9.65
-0.7%
$10.60
+9.8%
-21.1%$1.03B$371.67M12.70N/A
AWF
AllianceBernstein Global High Income Fund
N/A$11.22
+0.1%
N/A-1.3%$966.64MN/A0.00N/A
HQH
abrdn Healthcare Investors
N/A$17.95
+1.0%
N/A-0.4%$957.13MN/A0.00147,000
ASA
ASA Gold and Precious Metals
N/A$45.66
+2.8%
N/A+125.8%$956.33MN/A0.001,100Positive News
BBDC
BARINGS BDC
2.1913 of 5 stars
$8.81
-1.6%
$9.67
+9.8%
-12.7%$941.17M$286.17M9.1726News Coverage
Dividend Announcement
BCSF
Bain Capital Specialty Finance
3.2219 of 5 stars
$14.21
-1.2%
$16.50
+16.2%
-16.9%$932.81M$292.65M8.561,000Positive News

Related Companies and Tools


This page (NYSE:SAR) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners